Connect with us

Technology

Just – Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics

Published

on

Expands Just – Evotec Biologics partner-enablement and technology licensing model for proprietary continuous manufacturing platformEnables deployment of continuous manufacturing platform in partner-owned facilities to support higher productivity and flexibility compared with fed-batch technology biologics manufacturingModular manufacturing infrastructure, equipment and proprietary technology enable rapid and cost-efficient increase in capacity for biologics manufacturing

SEATTLE and HAMBURG, Germany, June 30, 2026 /PRNewswire/ — Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced the expansion of its Just – Evotec Biologics services with J.TRAIN, a new offering that enables biopharmaceutical companies to deploy Evotec’s proprietary continuous manufacturing technology directly within their own facilities on a turnkey basis. J.TRAIN brings together prefabricated modular cleanrooms and industry-standard manufacturing equipment with Just – Evotec Biologics’ cGMP-compliant process automation, designed to enable significantly faster and more cost-effective deployment than traditional manufacturing expansion.

Linda Zuckerman, PhD, EVP Global Head of Just – Evotec Biologics commented:

“J.TRAIN is a disruptive opportunity for industry to increase capacity and manufacture biologics at reduced costs and improved productivity, with deployment in as little as 18 months. It exemplifies the strategic shift in Just – Evotec Biologics toward a rapidly deployable, capital-lighter and technology-focused business model. We now combine technology licensing with process design and engineering capabilities, enabling the fast establishment and implementation of the most advanced continuous manufacturing processes, giving companies greater, tunable control over clinical and commercial materials. The model was validated by our December 2025 transaction with Sandoz, which included the provision of a manufacturing facility alongside a license to our proprietary manufacturing technology, demonstrating both its feasibility and scalability.”

Unveiled in April 2026 at the INTERPHEX conference in New York City, J.TRAIN allows customers and partners to establish high-performance biologics manufacturing capacity on their own premises, effectively embedding advanced manufacturing capabilities directly into their operations. Proprietary automation scripts for continuous process control, as well as digital validation, documentation and training protocols are all designed to significantly streamline implementation and ensure regulatory readiness.

J.TRAIN represents a step change in productivity and efficiency compared to conventional fed-batch approaches. It can enable the production of more than 500 kilograms of drug substance from less than 10,000 square feet of cleanroom space, achieving productivity levels more than ten times traditional methods. This efficiency is expected to translate into substantially lower operating costs per unit mass while allowing production scale to be flexibly adjusted through the duration of manufacturing runs rather than the size of the facility. The integrated nature of the J.TRAIN design allows for rapid transitions between products, minimizing downtime and supporting multi-product manufacturing environments.

With deployment timelines of approximately 18 months, J.TRAIN offers a significantly faster pathway to capacity expansion compared to traditional biologics manufacturing facilities. This shorter build time positions the solution as a compelling alternative for companies seeking to rapidly increase manufacturing capabilities in response to growing demand.

About Just – Evotec Biologics

Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform company that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com.

About Evotec SE

Evotec is a life science company that is pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and advanced technologies, we accelerate the journey from concept to cure — faster, smarter, and with greater precision. Our expertise spans small molecules, biologics, cell therapies and associated modalities, supported by proprietary platforms such as Molecular Patient Databases, PanOmics and iPSC-based disease modeling. With flexible partnering models tailored to our customers’ needs, we work with all Top 20 Pharma companies, over 800 biotechs, academic institutions, and healthcare stakeholders. Our offerings range from standalone services to fully integrated R&D programs and long-term strategic partnerships, combining scientific excellence with operational agility. Through Just – Evotec Biologics, we redefine biologics development and manufacturing to improve accessibility and affordability. With a strong portfolio of over 100 proprietary R&D assets, most of them being co-owned, we focus on key therapeutic areas including oncology, cardiovascular and metabolic diseases, neurology, and immunology. Evotec’s global team of more than 4,500 experts operates from sites in Europe and the U.S., offering complementary technologies and services as synergistic centers of excellence. Learn more at www.evotec.com and follow us on LinkedIn and X/Twitter @Evotec. 

Forward-looking statements

This announcement contains forward-looking statements concerning future events, including the proposed offering and listing of Evotec’s securities. Words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “should,” “target,” “would” and variations of such words and similar expressions are intended to identify forward-looking statements. Such statements include comments regarding Evotec’s expectations for revenues, Group EBITDA and unpartnered R&D expenses. These forward-looking statements are based on the information available to, and the expectations and assumptions deemed reasonable by Evotec at the time these statements were made. No assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of Evotec. Evotec expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Evotec’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Investor Relations and Media Contact
Dr. Sarah Fakih
EVP Head of Global Communications & Investor Relations
Sarah.Fakih@evotec.com 

 

View original content:https://www.prnewswire.com/news-releases/just–evotec-biologics-launches-jtrain-to-deliver-turnkey-continuous-manufacturing-for-biologics-302814150.html

SOURCE Evotec SE

Continue Reading

Technology

Toku launches Makimoto Flows, a visual builder for speech AI pipelines, taking its open-source initiative beyond transcription

Published

on

By

Developers can chain transcription, summarisation and call tagging on one canvas, test each step and export the pipeline as code, with every step processed in Singapore

SINGAPORE, Oct. 21, 2026 /PRNewswire/ — Toku Ltd. (SGX: TKU), a Singapore-headquartered AI-powered customer experience (CX) platform, has launched Makimoto Flows (“Flows”), a visual builder within its open-source conversational AI initiative where developers assemble speech AI pipelines block by block and test each stage on a recorded call. Flows is now live at makimoto.ai.

On the Flows canvas, developers connect blocks to build a speech AI pipeline and test each step individually. The Transcribe block converts audio into text using Kawa, the Summarise block generates a topic and short summary from the transcript, and the Tags block classifies each call across seven categories, including customer sentiment. Developers can see how audio moves from transcription to analysis, and control how each stage connects and runs. Every block runs in Singapore, so audio, transcripts and the resulting analysis stay in-country.

The Chained Analysis starter template puts these blocks together in one click, and developers can adjust any block and rerun it to compare results. Each block maps to a Makimoto API endpoint, and any flow can be exported as ready-to-run Python code, so developers can take the same capabilities into their own code for applications such as call recaps and call triage.

“Developers should have control over how their voice AI works, from the models they use to the way each stage connects. That is the principle behind Makimoto. Flows puts the orchestration layer in front of them: they can build a pipeline, run a recorded call through it and see what each step produces before anything reaches their customers. Models will keep changing. The ability to compose them, and to know where they run, is what lasts,” said Thomas Laboulle, Founder and CEO at Toku.

Flows builds on the composable architecture Toku set out when it introduced Makimoto in April 2026, and takes the initiative beyond transcription. Kawa, released on schedule on 1 July 2026, established the transcription layer through a Singapore-hosted API; summarisation and tagging endpoints followed in September; Flows now lets developers compose them visually. Next, Makimoto plans to add audio preparation blocks, starting with noise filtering, giving developers more control over how recordings are processed before transcription.

By pairing open-source development with enterprise-grade deployment, Makimoto complements Toku’s existing customer experience platform and supports long-term innovation opportunities across the Group’s AI roadmap.

Developers can create a free account at makimoto.ai, open the Chained Analysis template and run a sample recording, or one of their own call recordings, through it; each account includes 1,000 free minutes. Feedback reaches the Makimoto team directly from the portal.

About Toku

Headquartered in Singapore, Toku Ltd. (SGX Catalist: TKU) is a cloud-native, AI-powered customer experience platform purpose-built for enterprises operating in complex, multi-market environments. With deep roots in the APAC region and an expanding global footprint, Toku’s modular 360° CX Platform orchestrates customer interactions across voice, chat, email and digital channels while managing regulatory, linguistic and infrastructure complexity at scale.

Built on end-to-end ownership of its technology stack, from carrier-grade connectivity to AI applications, Toku delivers enterprise-grade security, reliability and deployment flexibility in commercial cloud, private data centres and hybrid environments. Its AI capabilities include transcription, summarisation, sentiment analysis, conversation analytics and governed virtual agents, designed to integrate seamlessly with enterprise systems and customer data.

Trusted by leading enterprises and public-sector organisations, Toku helps organisations streamline operations, scale customer engagement and deliver consistent experiences in fragmented markets worldwide.

For more information about Toku, visit toku.co.

About Makimoto

Makimoto is Toku’s open-source initiative, operated through Makimoto Technology Pte Ltd, a wholly owned subsidiary of the Toku Group, dedicated to building composable conversational AI infrastructure for Asia-Pacific. Its releases include Makimoto Kawa, a Singapore-hosted transcription API; summarisation and tagging endpoints; and Makimoto Flows, a visual builder for composing speech AI pipelines. For more information about Makimoto, visit makimoto.ai.

Forward-Looking Statements

This press release contains forward-looking statements regarding Toku’s expansion plans, business strategy and planned product releases. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Toku undertakes no obligation to update these statements to reflect subsequent events or circumstances.

Sponsor’s Statement

Toku Ltd. (the “Company”) was listed on Catalist of the Singapore Exchange Securities Trading Limited (the “Exchange”) on 22 January 2026. The initial public offering of the Company was sponsored by PrimePartners Corporate Finance Pte. Ltd. (the “Sponsor”). This press release has been reviewed by the Sponsor. It has not been examined or approved by the Exchange and the Exchange assumes no responsibility for the contents of this press release, including the correctness of any of the statements or opinions made or reports contained in this press release. The contact person for the Sponsor is Ms. Ng Shi Qing, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg.

Investor Relations Contact:
investor.relations@toku.co

Developers and Partners:
contact@makimoto.ai  

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/toku-launches-makimoto-flows-a-visual-builder-for-speech-ai-pipelines-taking-its-open-source-initiative-beyond-transcription-302914906.html

SOURCE Toku Ltd.

Continue Reading

Technology

Conscious Spark LLC Launches Alphimiya® Neuro-Recalibration Framework Designed to Resolve C-Suite Revenue Plateaus

Published

on

By

New research-backed neuro-recalibration framework targets the autonomic nervous system’s threat response to managing high financial amounts, offering enterprise leaders a biological pathway to scaling.

ANTALYA, Turkey and ALBUQUERQUE, N.M., Oct. 21, 2026 /PRNewswire/ — Conscious Spark LLC, a research and advisory firm specializing in applied neuroscience for executive leadership, today announced the official launch of Alphimiya®, a proprietary C-suite neuro-recalibration framework designed to resolve corporate revenue plateaus by upgrading the biological capacity of enterprise decision-makers.

Developed to address the root causes of stalled enterprise growth, the Alphimiya® framework targets the human autonomic nervous system’s subconscious threat response to managing high financial amounts. When commercial leaders and CEOs attempt to scale past historical capital thresholds without recalibrating their stress response, the body’s natural survival mechanism triggers decision fatigue, strategic risk aversion, and systemic self-sabotage. Alphimiya® recalibrates this biological safety brake, enabling executive teams to hold, absorb, and scale larger financial volumes without physiological or operational friction.

“A corporate revenue plateau is rarely an operational or marketing failure; it is a biological safety brake embedded within executive leadership,” stated Dr. Ahmed Al-Nashi, Founder of Conscious Spark LLC. “When managing high financial amounts triggers an underlying physical stress response, the enterprise subconsciously contracts to remain in its perceived safe zone. Alphimiya® removes that biological friction, allowing C-level leaders to multiply revenue with calm, biological authority.”

The Alphimiya® framework restructures executive performance across three core operational pillars:

Sovereign Enterprise Scaling: Expands the nervous system’s tolerance for high-stakes capital, allowing leadership teams to scale revenue without experiencing executive burnout.

High-Value Deal Execution: Regulates autonomic stress responses during multi-million-dollar negotiations and volatile market entries, eliminating hesitation under pressure.

Restored Strategic Clarity: Removes chronic decision fatigue across C-suite teams, restoring mental focus and strategic presence inside and outside the boardroom.

By recalibrating the autonomic nervous system’s response to high capital exposure, Alphimiya® removes the subconscious biological brakes that lock corporate revenue at a standstill. Senior C-level executives and enterprise leadership teams seeking to evaluate their organization’s biological capacity can access the official executive briefing, case studies, and framework assessment directly at https://alphimiya.co/.

About Conscious Spark LLC

Conscious Spark LLC is a U.S.-registered firm specializing in executive education, training, and strategic performance consulting. Pioneering applied neuroscience for C-level leaders, founders, and commercial decision-makers, the firm utilizes its proprietary Alphimiya® methodology to enable leadership teams to recalibrate biological stress responses, resolve revenue ceilings, and build scalable corporations.

Media Relations Team
Conscious Spark LLC
Email: hello@consciousspark.online 
Website: https://alphimiya.co/

View original content to download multimedia:https://www.prnewswire.com/news-releases/conscious-spark-llc-launches-alphimiya-neuro-recalibration-framework-designed-to-resolve-c-suite-revenue-plateaus-302901454.html

SOURCE Conscious Spark LLC

Continue Reading

Technology

Daffodil Software Brings Multilingual Conversational AI to Aadhaar’s Udai Mascot

Published

on

By

GURUGRAM, India, Oct. 21, 2026 /PRNewswire/ — Daffodil Software showcased an AI-powered conversational experience featuring UIDAI’s Udai mascot at Aadhaar Samvaad 2026. Developed by Daffodil Software, the assistant is designed to help users access Aadhaar-related information through natural conversation, using official UIDAI as its reference knowledge base.

Daffodil Software has developed Udai, an AI-powered virtual mascot that helps users get clear, reliable answers about Aadhaar simply by talking to it. The assistant was showcased at Aadhaar Samvaad 2026, held in Kolkata on 29 September, coinciding with the 17th Aadhaar Day, where visitors watched it listen, respond, and gesture in real time in their own language.

For most people, questions about Aadhaar come up in daily life, and they usually need answers fast. Which documents do I need for an address change? How much does an update cost? How do I link Aadhaar to my bank account or mobile number? The answers exist, but finding them usually means working through long help pages and documents.

 Udai is designed to answer exactly these questions in a natural conversation, without anyone having to search through long help pages.

A conversation in the user’s own language

Udai speaks and understands 11 languages: Hindi, Tamil, Bengali, Telugu, Kannada, Malayalam, Marathi, Gujarati, Punjabi, Odia, and English. A user simply asks a question. Udai listens, works out the answer, and replies in the same language, with natural speech, matching lip movements and expressive hand gestures.

What sets Udai apart is how it is built. AI avatars rely on expensive, specialised graphics hardware to bring a face to life. Udai takes a simpler route. The character is created from pre-filmed footage, and its lip movements are matched to its speech in real time using lightweight processing that runs in a web browser.

The result is a smooth experience at 24 frames per second on ordinary servers, at a fraction of the usual cost per user. For a programme that serves hundreds of millions of people, that efficiency is what turns a nationwide rollout from an ambition into a practical plan.

“Our focus with Udai was to make Aadhaar-related information easier to access through natural conversation. Combining multilingual voice interaction with official reference content allowed our team to build an experience that is practical, approachable, and useful to users,” said Yogesh Agarwal, Founder and CEO, Daffodil Software.

Answers drawn only from official sources

The assistant uses official UIDAI material as its reference knowledge base: frequently asked questions, provisions of the Aadhaar Act, and government policy documents on Aadhaar services. It covers the topics users ask about most:

Enrolment and registrationAddress and demographic updatesFees, required documents and eligibilityeKYC and Virtual IDLinking Aadhaar with bank accounts, PAN and mobile numbersmAadhaar servicesGrievance redressal

Users don’t need to phrase their questions in any particular way. Udai understands everyday language, whether a question is spoken in English, Hindi, or asked in a mix of both, and finds the most relevant official information to answer it.

Built to be accurate, respectful, and secure

When a public service speaks directly to users, trust matters as much as convenience. Udai is protected by three layers of safeguards.

Accuracy first. Udai answers only from its verified knowledge base. Responses are grounded in a curated knowledge base of official UIDAI material. If a question falls outside Aadhaar, it guides the user back rather than offering an answer it cannot stand behind.

Respectful conversations. A screening layer catches abusive or offensive language in English, Hindi, and Hinglish before it reaches the assistant. Screening is designed to identify abusive language while supporting legitimate queries

Protection against misuse. Udai cannot be talked into abandoning its role, pretending to be someone else, revealing its internal setup, or answering beyond its approved scope. These checks work almost instantly, so users experience no delay.

What comes next?

Udai is planned to roll out in two phases.

In the first phase, the mascot will be placed in Aadhaar Centres. Visitors will be able to check information and understand processes on their own, such as which documents they need for an address change. This frees centre staff to focus on their core work instead of answering the same questions again and again.

In the second phase, Udai will come to the Aadhaar website and mobile app, taking the place of the current text-based chatbot, which was also built by Daffodil.

About Daffodil Software

Daffodil Software is a software engineering and AI solutions company serving businesses across industries. Its services span software consulting, product engineering, UI/UX design, AI/ML development, quality assurance, cloud and DevOps, and maintenance. The company serves sectors including healthcare, fintech, banking, technology, and digital commerce. Its client portfolio includes organizations such as the Reserve Bank of India, Mount Sinai Hospital, Maruti, Samsung, Pramerica Insurance, and Dangote Group. Daffodil Software has also been featured in industry research and recognition by Gartner, Everest Group, Zinnov, and Frost & Sullivan. For more information, visit https://www.daffodilsw.com

Media contact

Kunwar Pal Singh
media-relations@daffodilsw.com

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/daffodil-software-brings-multilingual-conversational-ai-to-aadhaars-udai-mascot-302914965.html

Continue Reading

Trending